Keattiyoat Wattanakit1, Mary Cushman. 1. Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Abstract
PURPOSE OF REVIEW: An estimated 13% of Americans have kidney disease. We sought to describe the association of kidney disease with risk of venous thromboembolism and discuss possible mechanisms explaining this association. RECENT FINDINGS: All severities of kidney disease appear to increase the risk of venous thromboembolism. In the general population the risk associated with mild to moderate kidney disease is 1.3-2-fold increased, and present even for microalbuminuria, although stage 1 chronic kidney disease itself has not been studied. End-stage renal disease is also associated with a 2.3-fold increased risk, compared to the general population. Although data are limited, risk increases after kidney transplant and with nephrotic syndrome as well. SUMMARY: Rates of kidney disease are increasing rapidly in the population and kidney disease is a risk factor for venous thromboembolism. An improved understanding of mechanisms linking kidney disease with venous thromboembolism will allow further study of best prevention efforts.
PURPOSE OF REVIEW: An estimated 13% of Americans have kidney disease. We sought to describe the association of kidney disease with risk of venous thromboembolism and discuss possible mechanisms explaining this association. RECENT FINDINGS: All severities of kidney disease appear to increase the risk of venous thromboembolism. In the general population the risk associated with mild to moderate kidney disease is 1.3-2-fold increased, and present even for microalbuminuria, although stage 1 chronic kidney disease itself has not been studied. End-stage renal disease is also associated with a 2.3-fold increased risk, compared to the general population. Although data are limited, risk increases after kidney transplant and with nephrotic syndrome as well. SUMMARY: Rates of kidney disease are increasing rapidly in the population and kidney disease is a risk factor for venous thromboembolism. An improved understanding of mechanisms linking kidney disease with venous thromboembolism will allow further study of best prevention efforts.
Authors: R A Kraaijenhagen; P S in't Anker; M M Koopman; P H Reitsma; M H Prins; A van den Ende; H R Büller Journal: Thromb Haemost Date: 2000-01 Impact factor: 5.249
Authors: Daniel P Tveit; Iman O Hypolite; Paul Hshieh; David Cruess; Lawrence Y Agodoa; Paul G Welch; Kevin C Abbott Journal: Am J Kidney Dis Date: 2002-05 Impact factor: 8.860
Authors: Michael G Shlipak; Linda F Fried; Casey Crump; Anthony J Bleyer; Teri A Manolio; Russell P Tracy; Curt D Furberg; Bruce M Psaty Journal: Circulation Date: 2003-01-07 Impact factor: 29.690
Authors: Mary Cushman; Aaron R Folsom; Lu Wang; Nena Aleksic; Wayne D Rosamond; Russell P Tracy; Susan R Heckbert Journal: Blood Date: 2002-09-26 Impact factor: 22.113
Authors: Aaron R Folsom; Pamela L Lutsey; Brad C Astor; Keattiyoat Wattanakit; Susan R Heckbert; Mary Cushman Journal: Nephrol Dial Transplant Date: 2010-03-29 Impact factor: 5.992
Authors: Megan V Yanik; Marguerite R Irvin; T Mark Beasley; Pamala A Jacobson; Bruce A Julian; Nita A Limdi Journal: Pharmacotherapy Date: 2017-11-02 Impact factor: 4.705
Authors: Andrew Srisuwananukorn; Rasha Raslan; Xu Zhang; Binal N Shah; Jin Han; Michel Gowhari; Robert E Molokie; Victor R Gordeuk; Santosh L Saraf Journal: Blood Adv Date: 2020-05-12
Authors: Daniel Contaifer; Daniel E Carl; Urszula Osinska Warncke; Erika J Martin; Bassem M Mohammed; Benjamin Van Tassell; Donald F Brophy; Charles E Chalfant; Dayanjan S Wijesinghe Journal: J Lipid Res Date: 2016-12-19 Impact factor: 5.922